C07D 211/72
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
C07D211/72 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,227 US grants and 853 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,227
- Published applications
- 853
- Assignees
- 511
- Inventors
- 3,287
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 27 | 0 |
| 1978 | 22 | 0 |
| 1979 | 25 | 0 |
| 1980 | 36 | 0 |
| 1981 | 24 | 0 |
| 1982 | 21 | 0 |
| 1983 | 20 | 0 |
| 1984 | 14 | 0 |
| 1985 | 22 | 0 |
| 1986 | 18 | 0 |
| 1987 | 19 | 0 |
| 1988 | 25 | 0 |
| 1989 | 21 | 0 |
| 1990 | 20 | 0 |
| 1991 | 19 | 0 |
| 1992 | 24 | 0 |
| 1993 | 24 | 0 |
| 1994 | 27 | 0 |
| 1995 | 24 | 0 |
| 1996 | 28 | 0 |
| 1997 | 38 | 0 |
| 1998 | 35 | 0 |
| 1999 | 31 | 0 |
| 2000 | 31 | 0 |
| 2001 | 18 | 6 |
| 2002 | 31 | 37 |
| 2003 | 31 | 38 |
| 2004 | 24 | 46 |
| 2005 | 20 | 41 |
| 2006 | 22 | 51 |
| 2007 | 20 | 34 |
| 2008 | 18 | 27 |
| 2009 | 20 | 39 |
| 2010 | 34 | 54 |
| 2011 | 24 | 32 |
| 2012 | 29 | 26 |
| 2013 | 26 | 34 |
| 2014 | 27 | 29 |
| 2015 | 31 | 27 |
| 2016 | 19 | 35 |
| 2017 | 28 | 30 |
| 2018 | 27 | 36 |
| 2019 | 27 | 26 |
| 2020 | 27 | 31 |
| 2021 | 25 | 37 |
| 2022 | 19 | 32 |
| 2023 | 13 | 31 |
| 2024 | 20 | 27 |
| 2025 | 15 | 31 |
| 2026 | 14 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Imine compounds as well as preparation method therefor and use thereof27 Aug 2026US 2026/0248763 A1Bio Genuine (Shanghai) Biotech Co., Ltd
- Globodera pallida control agent20 Aug 2026US 2026/0240154 A1National Agriculture and Food Research Organization
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Composition for preventing or treating cancer diseases comprising aryl-piperidine derivative20 Aug 2026US 2026/0242336 A1Korea Institute of Radiological & Medical Sciences
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
Most cited
By later US patents
- Methods and compositions for determining the sequence of nucleic acid molecules245US 6,312,893 B1QIAGEN Genomics, Inc. · 2001
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- 4-substituted piperidine derivatives123US 7,572,913 B2Bioaxone Therapeutique Inc. · 2009
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Fluorescent viability assay using cyclic-substituted unsymmetrical cyanine dyes112US 5,534,416 AMolecular Probes, Inc. · 1996